FIA
RGNX icon

FNY Investment Advisers’s Regenxbio RGNX Stock Holding History

FNY Investment Advisers’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,995
Closed -$48K – 1382
2025
Q3 		$48K Hold
4,995
– – 0.02% 509
2025
Q2 		$41K Sell
4,995
-5
-0.1% -$42 0.02% 443
2025
Q1 		$35K Buy
+5,000
New +$37.2K 0.02% 340
2018
Q4 		– Sell
-1,500
Closed -$113K – 969
2018
Q3 		$113K Buy
1,500
+444
+42% +$32K 0.03% 259
2018
Q2 		$75K Buy
+1,056
New +$50.4K 0.03% 251

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

FNY Investment Advisers's RGNX Position: Q4 2025 in Review

FNY Investment Advisers sold out of Regenxbio (RGNX) in Q4 2025, closing a stake of 4,995 shares — an estimated $48K sold.

FNY Investment Advisers first reported a position in RGNX in Q2 2018 and held it in 5 quarters. The position peaked at $113K in Q3 2018. 174 funds tracked by Wall St. Rank hold RGNX as of Q4 2025.

  • FNY Investment Advisers reported no remaining Regenxbio position as of Q4 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 4,995 Regenxbio shares in Q4 2025, an estimated $48K.
  • FNY Investment Advisers first reported a position in Regenxbio in Q2 2018 and held it in 5 quarters.
  • FNY Investment Advisers's Regenxbio position peaked at $113K in Q3 2018.
  • 174 funds tracked by Wall St. Rank held Regenxbio as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.